IRLAB Therapeutics AB
STO:IRLAB A

Watchlist Manager
IRLAB Therapeutics AB Logo
IRLAB Therapeutics AB
STO:IRLAB A
Watchlist
Price: 12.6 SEK -1.95%
Market Cap: 652.5m SEK
Have any thoughts about
IRLAB Therapeutics AB?
Write Note

IRLAB Therapeutics AB
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

IRLAB Therapeutics AB
Total Liabilities & Equity Peer Comparison

Comparables:
CALTX
CAMX
S
SECARE
MOB
I
FLERIE

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
IRLAB Therapeutics AB
STO:IRLAB A
Total Liabilities & Equity
kr177.1m
CAGR 3-Years
-22%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
Calliditas Therapeutics AB
STO:CALTX
Total Liabilities & Equity
kr1.7B
CAGR 3-Years
14%
CAGR 5-Years
20%
CAGR 10-Years
N/A
Camurus AB
STO:CAMX
Total Liabilities & Equity
kr3.4B
CAGR 3-Years
49%
CAGR 5-Years
41%
CAGR 10-Years
N/A
S
Swedencare AB (publ)
STO:SECARE
Total Liabilities & Equity
kr10B
CAGR 3-Years
56%
CAGR 5-Years
136%
CAGR 10-Years
N/A
Moberg Pharma AB (publ)
STO:MOB
Total Liabilities & Equity
kr634.7m
CAGR 3-Years
10%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Total Liabilities & Equity
kr4.4B
CAGR 3-Years
107%
CAGR 5-Years
142%
CAGR 10-Years
N/A

See Also

What is IRLAB Therapeutics AB's Total Liabilities & Equity?
Total Liabilities & Equity
177.1m SEK

Based on the financial report for Dec 31, 2023, IRLAB Therapeutics AB's Total Liabilities & Equity amounts to 177.1m SEK.

What is IRLAB Therapeutics AB's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
-5%

Over the last year, the Total Liabilities & Equity growth was -45%. The average annual Total Liabilities & Equity growth rates for IRLAB Therapeutics AB have been -22% over the past three years , -5% over the past five years .

Back to Top